In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The price of Syndax Pharmaceuticals Inc (NASDAQ: SNDX) closed at $19.89 in the last session, up 0.71% from day before closing price of $19.75. In other words, the price has increased by $0.71 from its previous closing price. On the day, 0.69 million shares were traded. SNDX stock price reached its highest trading level at $20.24 during the session, while it also had its lowest trading level at $19.78.
Ratios:
We take a closer look at SNDX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 10.50 and its Current Ratio is at 10.50. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on June 28, 2024, initiated with a Buy rating and assigned the stock a target price of $37.
On January 31, 2024, Scotiabank Downgraded its rating to Sector Perform which previously was Sector Outperform and also lowered its target price recommendation from $36 to $23.
On December 22, 2023, Mizuho started tracking the stock assigning a Buy rating and target price of $45.Mizuho initiated its Buy rating on December 22, 2023, with a $45 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 14 ’24 when Goldan Keith A. bought 1,250 shares for $20.03 per share. The transaction valued at 25,037 led to the insider holds 52,623 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SNDX now has a Market Capitalization of 1693422592 and an Enterprise Value of 1260578560. For the stock, the TTM Price-to-Sale (P/S) ratio is 483.61 while its Price-to-Book (P/B) ratio in mrq is 3.89. Its current Enterprise Value per Revenue stands at 360.165 whereas that against EBITDA is -4.377.
Stock Price History:
Over the past 52 weeks, SNDX has reached a high of $25.34, while it has fallen to a 52-week low of $11.22. The 50-Day Moving Average of the stock is 2.94%, while the 200-Day Moving Average is calculated to be -5.95%.
Shares Statistics:
According to the various share statistics, SNDX traded on average about 992.08K shares per day over the past 3-months and 663550 shares per day over the past 10 days. A total of 84.83M shares are outstanding, with a floating share count of 79.45M. Insiders hold about 6.64% of the company’s shares, while institutions hold 97.03% stake in the company. Shares short for SNDX as of 1727654400 were 10081997 with a Short Ratio of 10.16, compared to 1724976000 on 9494296. Therefore, it implies a Short% of Shares Outstanding of 10081997 and a Short% of Float of 11.95.
